Other AbbVie drugs, including its once-best-selling multiuse medication Humira, have been targeted by new provisions in the IRA, too. Humira was among the first group of drugs that faced a penalty under a new law prohibiting drug prices from growing by more than the rate of inflation.

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in Medicare.

The U.S. government named 15 drugs that will be subject to the second round of price negotiations by Medicare, including Ozempic and Wegovy, the drugs at the center of the weight-loss craze. The Biden administration said the drugs account for $41 billion in annual Medicare spending,